BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11230836)

  • 1. Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS Study). QUinapril on Vascular Ace and Determinants of Ischemia.
    Oosterga M; Voors AA; Pinto YM; Buikema H; Grandjean JG; Kingma JH; Crijns HJ; van Gilst WH
    Am J Cardiol; 2001 Mar; 87(5):542-6. PubMed ID: 11230836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The QUinapril Ischemic Event Trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function.
    Pitt B; O'Neill B; Feldman R; Ferrari R; Schwartz L; Mudra H; Bass T; Pepine C; Texter M; Haber H; Uprichard A; Cashin-Hemphill L; Lees RS;
    Am J Cardiol; 2001 May; 87(9):1058-63. PubMed ID: 11348602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
    Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
    Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
    Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
    Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
    Pepine CJ; Rouleau JL; Annis K; Ducharme A; Ma P; Lenis J; Davies R; Thadani U; Chaitman B; Haber HE; Freedman SB; Pressler ML; Pitt B;
    J Am Coll Cardiol; 2003 Dec; 42(12):2049-59. PubMed ID: 14680725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical data: AVERT and QUO VADIS.
    O'Neill BJ
    Can J Cardiol; 2000 Aug; 16 Suppl E():32E-35E. PubMed ID: 10906624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BANFF: an update.
    Anderson T
    Can J Cardiol; 1999 Apr; 15 Suppl B():29B-30B. PubMed ID: 10350682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The angiotensin-converting enzyme inhibitor in the treatment of angina pectoris].
    Bussmann WD; Wittig RA; Brunner I; Bahrmann H
    Dtsch Med Wochenschr; 1992 Apr; 117(16):603-6. PubMed ID: 1568426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1.
    van Haelst PL; Tervaert JW; van Geel PP; Veeger NJ; Gurné O; Gans RO; van Gilst WH
    Eur J Vasc Endovasc Surg; 2003 Oct; 26(4):387-91. PubMed ID: 14512000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study.
    Mancini GB; Henry GC; Macaya C; O'Neill BJ; Pucillo AL; Carere RG; Wargovich TJ; Mudra H; Lüscher TF; Klibaner MI; Haber HE; Uprichard AC; Pepine CJ; Pitt B
    Circulation; 1996 Aug; 94(3):258-65. PubMed ID: 8759064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does quinapril improve coronary vasoconstriction in vasospastic angina?].
    Anzai H; Saijo T; Nakajima R; Tezuka N; Takagi T; Tsunoda T; Kobayashi N; Nakamura S; Yamaguchi T
    J Cardiol; 2000 Dec; 36(6):379-86. PubMed ID: 11190581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinapril with high affinity to tissue angiotensin-converting enzyme reduces restenosis after percutaneous transcatheter coronary intervention.
    Okimoto T; Imazu M; Hayashi Y; Gomyo Y; Sekiguchi Y; Yanagihara K; Shimohara Y; Sumii K; Yamamoto H; Tadehara F; Toyofuku M; Kohno N
    Cardiovasc Drugs Ther; 2001 Jul; 15(4):323-9. PubMed ID: 11800416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: no answer yet. QUIET Investigators. QUinapril Ischemic Event Trial.
    Cashin-Hemphill L; Holmvang G; Chan RC; Pitt B; Dinsmore RE; Lees RS
    Am J Cardiol; 1999 Jan; 83(1):43-7. PubMed ID: 10073783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of myocardial blood flow to ischemic regions by angiotensin-converting enzyme inhibition with quinaprilat IV: a study using [15O] water dobutamine stress positron emission tomography.
    Schneider CA; Voth E; Moka D; Baer FM; Melin J; Bol A; Wagner R; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1999 Oct; 34(4):1005-11. PubMed ID: 10520782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.